These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 26755394)
1. Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase. Chen W; Dong G; He S; Xu T; Wang X; Liu N; Zhang W; Miao C; Sheng C Bioorg Med Chem Lett; 2016 Feb; 26(3):765-768. PubMed ID: 26755394 [TBL] [Abstract][Full Text] [Related]
2. Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Dragovich PS; Zhao G; Baumeister T; Bravo B; Giannetti AM; Ho YC; Hua R; Li G; Liang X; Ma X; O'Brien T; Oh A; Skelton NJ; Wang C; Wang W; Wang Y; Xiao Y; Yuen PW; Zak M; Zhao Q; Zheng X Bioorg Med Chem Lett; 2014 Feb; 24(3):954-62. PubMed ID: 24433859 [TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. Zheng X; Baumeister T; Buckmelter AJ; Caligiuri M; Clodfelter KH; Han B; Ho YC; Kley N; Lin J; Reynolds DJ; Sharma G; Smith CC; Wang Z; Dragovich PS; Oh A; Wang W; Zak M; Wang Y; Yuen PW; Bair KW Bioorg Med Chem Lett; 2014 Jan; 24(1):337-43. PubMed ID: 24279990 [TBL] [Abstract][Full Text] [Related]
10. Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities. Bai J; Liao C; Liu Y; Qin X; Chen J; Qiu Y; Qin D; Li Z; Tu ZC; Jiang S J Med Chem; 2016 Jun; 59(12):5766-79. PubMed ID: 27224875 [TBL] [Abstract][Full Text] [Related]
12. Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies. Clark DE; Waszkowycz B; Wong M; Lockey PM; Adalbert R; Gilley J; Clark J; Coleman MP Bioorg Med Chem Lett; 2016 Jun; 26(12):2920-2926. PubMed ID: 27158141 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT. Wang X; Xu TY; Liu XZ; Zhang SL; Wang P; Li ZY; Guan YF; Wang SN; Dong GQ; Zhuo S; Le YY; Sheng CQ; Miao CY Sci Rep; 2015 Jul; 5():12657. PubMed ID: 26227784 [TBL] [Abstract][Full Text] [Related]
14. Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors. Zheng X; Bauer P; Baumeister T; Buckmelter AJ; Caligiuri M; Clodfelter KH; Han B; Ho YC; Kley N; Lin J; Reynolds DJ; Sharma G; Smith CC; Wang Z; Dragovich PS; Oh A; Wang W; Zak M; Gunzner-Toste J; Zhao G; Yuen PW; Bair KW J Med Chem; 2013 Jun; 56(12):4921-37. PubMed ID: 23617784 [TBL] [Abstract][Full Text] [Related]
15. Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Dragovich PS; Bair KW; Baumeister T; Ho YC; Liederer BM; Liu X; Liu Y; O'Brien T; Oeh J; Sampath D; Skelton N; Wang L; Wang W; Wu H; Xiao Y; Yuen PW; Zak M; Zhang L; Zheng X Bioorg Med Chem Lett; 2013 Sep; 23(17):4875-85. PubMed ID: 23899614 [TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase. Oh A; Ho YC; Zak M; Liu Y; Chen X; Yuen PW; Zheng X; Liu Y; Dragovich PS; Wang W Chembiochem; 2014 May; 15(8):1121-30. PubMed ID: 24797455 [TBL] [Abstract][Full Text] [Related]
17. Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer. Zhang W; Zhang K; Yao Y; Liu Y; Ni Y; Liao C; Tu Z; Qiu Y; Wang D; Chen D; Qiang L; Li Z; Jiang S Eur J Med Chem; 2021 Feb; 211():113022. PubMed ID: 33239261 [TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel nicotinamide phosphoribosyl transferase (NAMPT) inhibitor via in silico screening. Takeuchi M; Niimi T; Masumoto M; Orita M; Yokota H; Yamamoto T Biol Pharm Bull; 2014; 37(1):31-6. PubMed ID: 24389478 [TBL] [Abstract][Full Text] [Related]
19. Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. Dong G; Chen W; Wang X; Yang X; Xu T; Wang P; Zhang W; Rao Y; Miao C; Sheng C J Med Chem; 2017 Oct; 60(19):7965-7983. PubMed ID: 28885834 [TBL] [Abstract][Full Text] [Related]
20. Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents. Li Y; Kong X; Chu X; Fu H; Feng X; Zhao C; Deng Y; Ge J Molecules; 2024 Jun; 29(12):. PubMed ID: 38930900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]